Anti-influenza virus activity of tricin, 4′,5,7-trihydroxy-3′,5′-dimethoxyfavone

Antiviral Chemistry and Chemotherapy

Volumn 22, Issue 1, 2012, Pages 1-11

  Yazawa, Kurumi ^a   Kurokawa, Masahiko ^b   Obuchi, Masatsugu ^c   Li, Ying ^a   Yamada, Rie ^a   Sadanari, Hidetaka ^a   Matsubara, Keiko ^a   Watanabe, Kunitomo ^d   Koketsu, Mamoru ^d   Tuchida, Yuuzo ^e   Murayama, Tsugiya ^a  

^a HOKURIKU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^d GIFU UNIVERSITY   (Japan)

^e Hououdou Co Ltd   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; FLAVONE DERIVATIVE; MATRIX PROTEIN; MESSENGER RNA; TRICIN; UNCLASSIFIED DRUG; VIRUS SIALIDASE; 3',5' DIMETHOXYFLAVONE; 3',5'-DIMETHOXYFLAVONE; FLAVONOID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFICACY; ENZYME INHIBITION; FEMALE; HEMAGGLUTINATION INHIBITION TEST; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; JAPAN; MALAYSIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SOLOMON ISLANDS; SURVIVAL TIME; UNITED STATES; VIRUS STRAIN; WEIGHT REDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; INFLUENZA VIRUS A; ORTHOMYXOVIRUS INFECTION;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; FLAVONES; FLAVONOIDS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84863106402     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.3851/IMP1782     Document Type: Article

References (35)

1. Akaike T, Ando M, Oda T, et al. Dependence on O2-generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. J Clin Invest 1990; 85:739-745.
2. Siberry GK. Complications of influenza infection in children. Pediatr Ann 2000; 29:683-690.
3. Nicholson KG, Aoki FY, Osterhaus AD, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Lancet 2000; 355:1845-1850.
4. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186.
5. Palese P. Influenza: old and new threats. Nat Med 2004; 10:S82-S87.
6. De Clercq E. Antiviral agents active against influenza A viruses. Nat Rev Drug Discov 2006; 5:1015-1025.
7. Pitts SR. Evidence-based emergency medicine/systematic review abstract. Use of the neuraminidase inhibitor class of antiviral drugs for treatment of healthy adults with an acute influenza-like illness. Ann Emerg Med 2002; 39:552-554.
8. Englund JA, Champlin RE, Wyde PR, et al. Common emergence of amantadine- and rimantadine-resistant influenza A viruses in symptomatic immunocompromised adults. Clin Infect Dis 1998; 26:1418-1424.
9. McKimm-Breschkin J, Trivedi T, Hampson A, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother 2003; 47:2264-2272.
10. Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003; 41:742-750.
11. Kuboyama N, Fujii A, Tamura T. [Antitumor activities of bamboo leaf extracts (BLE) and its lignin (BLL)]. Nippon Yakurigaku Zasshi 1981; 77:579-596. Japanese
12. Shibata M, Kubo K, Onoda M. [Pharmacological studies on bamboo grass. (2) Central depressant and antitoxic actions of a water-soluble fraction (folin) extracted from Sasa albomarginata Makino et Shibata]. Nippon Yakurigaku Zasshi 1976; 72:531-541. Japanese.
13. Shibata M, Yamatake Y, Sakamoto M, Kanamori M, Takagi K. [Phamacological studies on bamboo grass (1). Acute toxicity and anti-inflammatory and antiulcerogenic activities of water-soluble fraction(Folin) extracted from Sasa albomarginata Makino et Shibata]. Nippon Yakurigaku Zasshi 1975; 71:481-490. Japanese.
14. Jassim SA, Naji MA. Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 2003; 95:412-427.
15. Sakai A, Watanabe K, Koketsu M, et al. Anti-human cytomegalovirus activity of constituents from Sasa albo-marginata (Kumazasa in Japan). Antivir Chem Chemother 2008; 19:125-132.
16. Loginova SI, Borisevich SV, Lykov M V, et al. [In vitro efficacy of ingavirin against the Mexican pandemic subtype H1N1 of influenza A virus, strains A/California/04/2009 and A/California/07/2009]. Antibiot Khimioter 2009; 54:15-17. Russian.
17. Lin X, Zhou J, Zhang Y, et al. Oseltamivir boosts 2009 H1N1 virus infectivity in vitro. Biochem Biophys Res Commun 2009; 390:1305-1308.
18. Morikane K. [Changing management of pandemic influenza]. Rinsho Byori 2010; 58:254-262. Japanese.
19. Kurokawa M, Imakita M, Kumeda CA, Shiraki K. Cascade of fever production in mice infected with influenza virus. J Med Virol 1996; 50:152-158.
20. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 1993; 15:532-534, 536-537.
21. Schweiger B, Zadow I, Heckler R, Timm H, Pauli G. Application of a fuorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol 2000; 38:1552-1558.
22. Spackman E, Senne DA, Myers TJ, et al. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002; 40:3256-3260.
23. Ge Q, McManus MT, Nguyen T, et al. RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003; 100:2718-2723.
24. Suzuki Y, Suzuki T, Matsumoto M. Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane. J Biochem 1983; 93:1621-1633.
25. Tsurita M, Kurokawa M, Imakita M, Fukuda Y, Watanabe Y, Shiraki K. Early augmentation of interleukin (IL)-12 level in the airway of mice administered orally with clarithromycin or intranasally with IL-12 results in alleviation of influenza infection. J Pharmacol Exp Ther 2001; 298:362-368.
26. Govorkova EA, Leneva IA, Goloubeva OG, Bush K, Webster RG. Comparison of effcacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses. Antimicrob Agents Chemother 2001; 45:2723-2732.
27. Chand P, Bantia S, Kotian PL, El-Kattan Y, Lin TH, Babu YS. Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo. Bioorg Med Chem 2005; 13:4071-4077.
28. Suzuki Y, Kato H, Naeve CW, Webster RG. Single-amino-acid substitution in an antigenic site of influenza virus hemagglutinin can alter the specificity of binding to cell membrane-associated gangliosides. J Virol 1989; 63:4298-4302.
29. Suzuki Y, Nakao T, Ito T, et al. Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains. Virology 1992; 189:121-131.
30. Weis W, Brown JH, Cusack S, Paulson JC, Skehel JJ, Wiley DC. Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 1988; 333:426-431.
31. Akuzawa K, Yamada R, Li Z, et al. Inhibitory effects of tricin derivative from Sasa albo-marginata on replication of human cytomegalovirus. Antiviral Res 2011; in press.
32. Lee SM, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008; 198:525-535.
33. Li W, Liu Y, Mukhtar MM, et al. Activation of interleukin-32 pro-infammatory pathway in response to influenza A virus infection. PLoS One 2008; 3:e1985.
34. Gebhardt BM, Varnell ED, Kaufman HE. Inhibition of cyclooxygenase 2 synthesis suppresses Herpes simplex virus type 1 reactivation. J Ocul Pharmacol Ther 2005; 21:114-120.
35. Carey MA, Bradbury JA, Rebolloso YD, Graves JP, Zeldin DC, Germolec DR. Pharmacologic inhibition of COX-1 and COX-2 in influenza A viral infection in mice. PLoS ONE 2010; 5:e11610.